ODC (ornithine decarboxylase) is a central regulator of cellular polyamine synthesis. ODC is a highly regulated enzyme stimulated by a variety of growth-promoting stimuli. ODC overexpression leads to cellular transformation. Cellular ODC levels are determined at transcriptional and translational levels and by regulation of its degradation. Here we review the mechanism of ODC degradation with particular emphasis on AzI (antizyme inhibitor), an ODC homologous protein that appears as a central regulator of ODC stability, cellular polyamine homoeostasis and cellular proliferation.
Introduction
ODC (ornithine decarboxylase) is the first rate-limiting enzyme in the biosynthesis pathway of polyamines in mammalian cells. ODC is a pyridoxal phosphate-dependent enzyme. In its active form ODC is a homodimer that contains two active sites located at the interface between the subunits [1] . ODC decarboxylates ornithine to form putrescine that is further converted into spermidine and spermine by the concerted action of S-adenosylmethionine decarboxylase, and spermidine and spermine synthetase respectively [2] . Although all cells contain polyamine biosynthesis machinery, most cells have an uptake system capable of transporting polyamines across the plasma membrane.
ODC degradation
ODC is characterized by an extremely rapid turn over rate. Actually, ODC is one of the most rapidly degraded proteins in eukaryotic cells. Interestingly, while the proteasome/ ubiquitin pathway accounts for the degradation of the vast majority of cellular short-lived proteins [3] , ODC is degraded by the 26 S proteasome without ubiquitination [4, 5] . Two segments were demonstrated to be necessary for ODC degradation. The first is a C-terminal segment encompassing the 37 most C-terminal amino acids that acts as a destabilizing signal [6] [7] [8] . The second, encompassing amino acids 117-140 mediates the interaction with a polyamine-stimulated protein termed Az (antizyme) that was demonstrated to be a central regulator of cellular polyamine homoeostasis. eukaryotic cellular gene. Az is expressed by regulated ribosomal frameshifting that combines two ORFs (open reading frames) to form a full-length functional protein [11, 12] . The ribosome that initiates translation at the initiation codon of the first ORF (ORF 0 ) encounters a termination codon shortly thereafter. Sequences located around this stop codon stimulate the subversion of the ribosome to the +1 reading frame (ORF1). This ribosomal frameshifting is stimulated by polyamines and therefore can be regarded as a cellular polyamine sensing mechanism.
Following its cloning [13] , it was demonstrated that Az inactivates ODC by capturing transient ODC monomers into an inactive ODC/Az heterodimer [14] . The ODC dimer is in a constant state of association and dissociation, a situation promoted by a relatively weak interaction between the ODC subunits [15, 16] . Since the affinity of Az for ODC subunits is greater than the affinity ODC subunits display for each other, the formation of Az/ODC heterodimers is preferred over the re-association of the ODC subunits. The association with Az inactivates ODC and targets it to ATP-dependent, ubiquitinindependent degradation by the 26 S proteasome [4, 5, 17] . Interaction with Az imposes a conformational change on ODC, exposing the C-terminal segment that serves as the recognition determinate [18] . Two segments of Az are required for targeting ODC to degradation. The C-terminal half (amino acids 104-183) is required for the interaction with ODC resulting in its inactivation but not in its degradation [14] . Another more N-terminal segment (amino acids 70-103) is required for targeting ODC to proteasomal degradation [14] .
Although interaction with Az is essential for stimulating the ubiquitin-independent degradation of ODC, this interaction is not required for the degradation of Az [19] . The rate of ODC degradation is greatly stimulated by a co-transfected Az. In contrast, co-transfected ODC does not change the rate of Az degradation. It was therefore concluded that, although Az is degraded by the proteasome (its degradation is inhibited by proteasome inhibitors), it is not degraded while presenting ODC to the proteasome [19] . Since Az degradation was inhibited in cells harbouring a thermosensitive allele of the ubiquitin-activating enzyme E1 that were shifted to the nonpermissive temperature, it was concluded that Az is degraded in a ubiquitin-dependent manner [19] . In addition to its ability to manipulate ODC degradation, Az inhibits cellular polyamine uptake activity via a yet unknown mechanism [20, 21] .
AzI (antizyme inhibitor) degradation
Although Az is clearly a central regulator of cellular polyamine levels, modulating both synthesis and transport, recent studies suggested that yet another protein termed antizyme inhibitor (AzI) might regulate the regulator [22] [23] [24] [25] [26] 32, 33] . AzI was originally identified in rat liver extracts based on its ability to prevent Az from inactivating and degrading ODC [22] . AzI shares extensive homology with ODC but it lacks ornithine decarboxylating activity [23, 24] . Az binds AzI more tightly than it binds ODC [25, 26] . Therefore AzI can rescue ODC from binding to Az and from being degraded. Although displaying strong binding to Az, the C-terminal segment of AzI differs significantly from that of ODC that serves as a degradation signal [8] . Despite this difference, AzI is a rapidly degraded protein [27] . Its degradation does not depend on the C-terminal segment that parallels the C-terminal degradation signal of ODC, or on interaction with Az. An AzI mutant with greatly reduced Az-binding capacity is still rapidly degraded, while a similar ODC mutant is stable. In fact, not only is interaction with Az not required for AzI degradation, but such interaction actually inhibited AzI degradation. Accumulation of AzI in cells harbouring mutant ubiquitin activating enzyme, lack of degradation in fraction-II of reticulocyte lysate (that is depleted of ubiquitin), and efficient ubiquitination of AzI both in vivo and in vitro demonstrated that AzI is degraded in a ubiquitin-dependent manner [27] . Interaction with Az inhibited AzI degradation by interfering with its ubiquitination, suggesting that as in the case of ODC the interaction with Az imposes a conformational change on AzI, but in this case the altered folding hides the AzI degradation signal. Replacement of the C-terminal segment of AzI with the parallel segment of ODC did not confer Az-dependent degradation on AzI, suggesting that the recognition by the ubiquitin system is dominant.
Role of AzI in cell growth and transformation
The rapid degradation that is a typical characteristic of important cellular regulatory proteins is compatible with the possibility that AzI plays a real physiological role in regulating cellular polyamines. This possibility is also supported by the following observations: (i) AzI mRNA is induced during growth stimulation of quiescent cells [24] ; (ii) downregulation of AzI expression reduced ODC and polyamine levels and cellular proliferation [28] ; (iii) AzI mRNA is elevated in gastric tumour compared with adjacent healthy tissue [29] ; and (iv) the human AzI gene is located in a region that is amplified in some tumours [30, 31] . More direct evidence that AzI regulates cellular polyamine homoeostasis and proliferation was obtained using AzI-overproducing cells [32, 33] . The resulting cells grew more rapidly than control cells, survive and grow in low serum, form colonies in soft agar and gave rise to tumours when injected into nude mice. Conversely, cells transiently transfected with AzIspecific siRNA (small interfering RNA) grew slower than the control cells. As could be expected from a molecule that neutralizes Az functions, AzI-overproducing cells display increased ODC activity [32, 33] and increased polyamine uptake activity [32] . It was suggested that neutralization of Az functions may not be the only mechanism by which AzI promotes cellular proliferation as AzI binds to and stabilizes cyclin D1 [33] . Increased ODC and AzI expression was observed in Ras-transformed cells [32, 34] , and Ras-transformations also induced polyamine uptake activity [32] . In light of the parallel increase in ODC and AzI in Ras-transformed cells, it is important to note that ODC-and AzI-overproducing cells markedly differ in their polyamine uptake activity. While AzI stimulates polyamine uptake, reduced uptake activity was observed in ODC-overproducing cells [32] . The decreased polyamine uptake activity in ODC-overexpressing cells is probably a result of induced Az expression. Coexpression of AzI together with ODC, as observed in Rastransformed cells, neutralizes the induced Az, thus negating the inhibition of the polyamine uptake activity.
Polyamines are essential for normal and abnormal cell growth. Cancer cells synthesize and take up large amounts of polyamines. Inhibiting growth of cancer cells through the use of polyamine synthesis inhibitors such as α-DFMO (α-difluoromethylornithine) is of important clinical potential. A major drawback of such synthesis inhibitors is that while they efficiently limit polyamine biosynthesis they have no effect on or even stimulate polyamine uptake. Polyamine uptake is increased by growth-promoting factors that induce ODC and in various transformed cells [35] . If increased ODC was the sole polyamine metabolism-related change accompanying cellular transformation, reduced polyamine uptake would be expected in transformed cells. Increased polyamine uptake activity in various transformed cells suggests that neutralization of Az occurs in these cells. Increased AzI provides such an Az neutralization mechanism.
In conclusion, we propose that both ODC and AzI can promote cell growth and transformation, and that both are relevant to cancer development. However, they affect cellular polyamine homoeostasis by different mechanisms: ODC directly elevates putrescine levels, leading to an increase in cellular polyamine synthesis and a decrease in polyamine transport activity. As a result, tumours overexpressing ODC are expected to be refractory to treatment with toxic polyamine analogues, but sensitive to polyamine synthesis inhibitors such as α-DFMO [32] . AzI, through negating Az function, elevates ODC (owing to its stabilization) and polyamine uptake activity. As a result, tumours containing increased AzI (alone or together with ODC) are not solely dependent on synthesis for maintaining their polyamines, and therefore will respond inefficiently to treatment with polyamine synthesis inhibitor. On the other hand, due to their elevated polyamine uptake activity, such tumour cells are more sensitive to toxic polyamine analogues [32] . It will therefore be of interest to determine ODC, Az and AzI levels in various tumours and in adjacent healthy tissues. Such information will help to determine whether synthesis inhibitors or toxic polyamine analogues should be used to inhibit tumour growth. The ability of AzI to directly stimulate cellular proliferation and its ability to assist the growth-promoting activity of ODC makes AzI an interesting therapeutic target.
